With a sharp increase in the incidence of cardiovascular disorders and mortalities in Europe, the need for early detection as well as cardiac interventional procedures has created enhanced scope for the uptake of cardiac catheterisation imaging systems.
Initiatives by healthcare authorities to revamp cardiac catheterisation labs are also likely to encourage the replacement of analog image intensifier systems with flat-panel digital ones, thereby stimulating market growth.
“Greater focus on the diagnosis and treatment of cardiac disorders is leading to increased interventional procedures, thereby creating the need for sophisticated cardiac imaging systems”, states Ms. Srividya Badrinarayanan, Industry Analyst at Frost & Sullivan. “Moreover, the trend of replacement of analog image intensifier by flat panel systems which offer improved image quality is reviving the market.”
The growing awareness of cardiovascular disorders (CVD) has led to a rise in the number of diagnostic procedures, thereby resulting in a spurt in interventional cardiac catheterisation procedures. A growing focus on efficient and non-invasive techniques of diagnostic cardiology such as computed tomography angiography (CTA) and magnetic resonance angiography (MRA) has also resulted in the augmented use of cardiovascular X-rays in catheterisation procedures.
Accordingly, revenues in the European cardiac catheterisation imaging systems market are anticipated to reach $196.6 million by 2009 from an estimated $144.1 million in 2004. The single plane cardiovascular imaging systems segment will continue dominating the overall market. At the same time, the biplane systems segment is also likely to boost market revenues.
However, while digital flat panel systems will enhance the efficiency of cardiac catheterisation labs in providing high-quality care and reducing waiting lists, their price will impose restraints on market growth. “The acceptance of digital systems has been hampered by the significant price difference that exists between analog and digital systems”, explains Ms. Badrinarayanan. “In addition, the total market has been affected by constant price erosion.”
Despite the decline in prices, cardiac catheterisation imaging systems still remain unaffordable to many healthcare institutions and imaging centres. Thus, justifying equipment price (particularly for new technology equipment) will become essential to prevent healthcare institutions from opting for refurbished equipment.